Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor
- PMID: 15025423
- DOI: 10.1080/00365510310003409
Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor
Abstract
Background: As carcinoid tumors produce and secrete serotonin, various serotonin markers in blood, plasma and urine have been used as diagnostic tools, and quantification of the urinary excretion of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) is the method most frequently used.
Methods: [3H]lysergic acid diethylamide ([3H]LSD) binding to the platelet serotonin 5-HT2A receptor was investigated in nine patients with carcinoid tumors. The possible effect of serotonin-rich food on the receptor binding was also investigated.
Results: B(max) for [3H]LSD binding was significantly lower in the carcinoid group than in the control group (mean +/- SD: 17.6 +/- 1.3 vs. 23.9 +/- 5.2 fmol/mg protein; p = 0.007). Kd for [3H]LSD binding was significantly higher in the carcinoid group than in the control group (median: 1.14 vs. 0.71 nmol/L; p = 0.03). B(max) was inversely related to the urinary 5-HIAA excretion, but the correlation did not reach statistical significance (r(s) = -0.57; p = 0.14). Intake of five bananas per day for one week had no effect on B(max) or Kd in healthy volunteers.
Conclusions: The results are consistent with a down-regulation of the 5-HT2A receptor as a response to the high serotonin levels found in patients with carcinoid tumors. Intake of serotonin-rich food does not affect the receptor characteristics. Further studies are needed to determine whether the platelet 5-HT2A receptor status can be used as a supplement to urinary 5-HIAA and other biochemical variables in carcinoid tumors.
Comment in
-
Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor.Scand J Clin Lab Invest. 2004;64(1):1-2. doi: 10.1080/00365510310003391. Scand J Clin Lab Invest. 2004. PMID: 15025422 No abstract available.
Similar articles
-
Urinary serotonin in the diagnosis of carcinoid tumors.Clin Chem. 1986 May;32(5):840-4. Clin Chem. 1986. PMID: 2421946
-
Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.Biol Psychiatry. 1998 May 15;43(10):774-80. doi: 10.1016/s0006-3223(97)00281-3. Biol Psychiatry. 1998. PMID: 9606533
-
Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers.Psychopharmacology (Berl). 1997 Sep;133(1):39-42. doi: 10.1007/s002130050368. Psychopharmacology (Berl). 1997. PMID: 9335078
-
Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature.Int J Pancreatol. 1998 Apr;23(2):153-64. doi: 10.1385/IJGC:23:2:153. Int J Pancreatol. 1998. PMID: 9629513 Review.
-
Recent developments in diagnosis and treatment of metastatic carcinoid tumours.Scand J Gastroenterol Suppl. 1993;200:87-93. doi: 10.3109/00365529309101582. Scand J Gastroenterol Suppl. 1993. PMID: 7517066 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials